The 9.1-CVSS vulnerability enables attackers to circumvent RCE protections in the de facto template engine for the Java ...

Because many password generators aren't as random as they seem, I built an improved one in Excel—and I'll show you exactly ...

They may look complex, but AI-generated passwords often follow predictable patterns that hackers can exploit. I'll show you ...

The modern web is a major pain to use without a password manager app. However, using such a service requires you to entrust your precious secrets to a third party. They could also be compromised, ...

Have you ever had Apple Passwords generate a new password that didn’t end up being saved correctly? Sometimes a website crashes at the wrong moment, or uses protocols that don’t exactly play nice with ...

Feb 23 (Reuters) - Drug developer Generate Biomedicines said on Monday it was targeting a valuation of up to $2.17 billion in its U.S. initial public offering, tapping into a resurgent biotech market ...

Generate Biomedicines Inc., a biotechnology firm using artificial intelligence in drug development, is seeking to raise as much as $425 millon in an initial public offering, as listing activity in the ...

Jake Peterson is Lifehacker’s Tech Editor, and has been covering tech news and how-tos for nearly a decade. His team covers all things technology, including AI, smartphones, computers, game consoles, ...

The era of AI has not been particularly great for cybersecurity. We know that vibe-coded websites and apps have been a hotbed of security flaws that leave the platforms vulnerable to attacks. It turns ...

Facepalm: As we continue waiting for it to find a cure for cancer, it seems there's something else that AI isn't very good at: generating passwords. New research suggests that asking large language ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min Generate:Biomedicines raised ...

Generate Biomedicines Inc. filed for an initial public offering, joining a growing list of biotechnology firms to leap to public markets as investors embrace the sector. The Somerville, ...